These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36076955)

  • 21. Erythropoietin in spinal cord injury.
    Matis GK; Birbilis TA
    Eur Spine J; 2009 Mar; 18(3):314-23. PubMed ID: 19030901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease.
    Thomas Tayra J; Kameda M; Yasuhara T; Agari T; Kadota T; Wang F; Kikuchi Y; Liang H; Shinko A; Wakamori T; Vcelar B; Weik R; Date I
    Brain Res; 2013 Mar; 1502():55-70. PubMed ID: 23380533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.
    Okutan O; Solaroglu I; Beskonakli E; Taskin Y
    J Clin Neurosci; 2007 Apr; 14(4):364-8. PubMed ID: 17236773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin and Its Derivates Modulate Mitochondrial Dysfunction after Diffuse Traumatic Brain Injury.
    Millet A; Bouzat P; Trouve-Buisson T; Batandier C; Pernet-Gallay K; Gaide-Chevronnay L; Barbier EL; Debillon T; Fontaine E; Payen JF
    J Neurotrauma; 2016 Sep; 33(17):1625-33. PubMed ID: 26530102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin-Induced Autophagy Protects Against Spinal Cord Injury and Improves Neurological Function via the Extracellular-Regulated Protein Kinase Signaling Pathway.
    Zhong L; Zhang H; Ding ZF; Li J; Lv JW; Pan ZJ; Xu DX; Yin ZS
    Mol Neurobiol; 2020 Oct; 57(10):3993-4006. PubMed ID: 32647973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
    Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
    Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-beta.
    Fang XQ; Fang M; Fan SW; Gu CL
    Chin Med J (Engl); 2009 Jul; 122(14):1631-5. PubMed ID: 19719963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.
    Adembri C; Massagrande A; Tani A; Miranda M; Margheri M; De Gaudio R; Pellegrini-Giampietro DE
    Crit Care Med; 2008 Mar; 36(3):975-8. PubMed ID: 18176311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed administration of recombinant human erythropoietin reduces apoptosis and inflammation and promotes myelin repair and functional recovery following spinal cord compressive injury in rats.
    Yang L; Yan X; Xu Z; Tan W; Chen Z; Wu B
    Restor Neurol Neurosci; 2015 Oct; 34(4):647-63. PubMed ID: 26444376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury.
    Pinzon A; Marcillo A; Pabon D; Bramlett HM; Bunge MB; Dietrich WD
    Exp Neurol; 2008 Sep; 213(1):129-36. PubMed ID: 18625498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of insulin-like growth factor 1 and erythropoietin protects against ischemic spinal cord injury in rabbits.
    Utada K; Ishida K; Tohyama S; Urushima Y; Mizukami Y; Yamashita A; Uchida M; Matsumoto M
    J Anesth; 2015 Oct; 29(5):741-8. PubMed ID: 26003536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms.
    Norimatsu Y; Ohmori T; Kimura A; Madoiwa S; Mimuro J; Seichi A; Yatomi Y; Hoshino Y; Sakata Y
    Am J Pathol; 2012 Apr; 180(4):1625-35. PubMed ID: 22417787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.
    Celik M; Gökmen N; Erbayraktar S; Akhisaroglu M; Konakc S; Ulukus C; Genc S; Genc K; Sagiroglu E; Cerami A; Brines M
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2258-63. PubMed ID: 11854521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergetic Induction of NGF With Diazoxide and Erythropoietin Attenuates Spinal Cord Ischemic Injury.
    Yamanaka K; Eldeiry M; Aftab M; Ryan TJ; Meng X; Weyant MJ; Fullerton DA; Reece TB
    J Surg Res; 2019 Jan; 233():124-131. PubMed ID: 30502238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATF3 is a neuron-specific biomarker for spinal cord injury and ischaemic stroke.
    Pan JZ; Wang Z; Sun W; Pan P; Li W; Sun Y; Chen S; Lin A; Tan W; He L; Greene J; Yao V; An L; Liang R; Li Q; Yu J; Zhang L; Kyritsis N; Fernandez XD; Moncivais S; Mendoza E; Fung P; Wang G; Niu X; Du Q; Xiao Z; Chang Y; Lv P; Huie JR; Torres-Espin A; Ferguson AR; Hemmerle DD; Talbott JF; Weinstein PR; Pascual LU; Singh V; DiGiorgio AM; Saigal R; Whetstone WD; Manley GT; Dhall SS; Bresnahan JC; Maze M; Jiang X; Singhal NS; Beattie MS; Su H; Guan Z
    Clin Transl Med; 2024 Apr; 14(4):e1650. PubMed ID: 38649772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin activates the phosporylated cAMP [adenosine 3'5' cyclic monophosphate] response element-binding protein pathway and attenuates delayed paraplegia after ischemia-reperfusion injury.
    Mares JM; Foley LS; Bell MT; Bennett DT; Freeman KA; Meng X; Weyant MJ; Cleveland JC; Fullerton DA; Puskas F; Reece TB
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):920-4. PubMed ID: 25500291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO.
    Bader A; Ebert S; Giri S; Kremer M; Liu S; Nerlich A; Günter CI; Smith DU; Machens HG
    Int J Nanomedicine; 2012; 7():1227-37. PubMed ID: 22419870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.
    Hooshmandi E; Motamedi F; Moosavi M; Katinger H; Zakeri Z; Zaringhalam J; Maghsoudi A; Ghasemi R; Maghsoudi N
    Neuroscience; 2018 Sep; 388():405-417. PubMed ID: 30102955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models.
    Tögel FE; Ahlstrom JD; Yang Y; Hu Z; Zhang P; Westenfelder C
    J Am Soc Nephrol; 2016 Nov; 27(11):3394-3404. PubMed ID: 26984884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.